Mitsubishi UFJ Trust & Banking
PCVX icon

Mitsubishi UFJ Trust & Banking’s Vaxcyte PCVX Stock Holding History

Mitsubishi UFJ Trust & Banking’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$183K Buy
+3,146
New +$171K ﹤0.01% 1349

Other funds holding PCVX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Mitsubishi UFJ Trust & Banking's PCVX Position: Q2 2026 in Review

Mitsubishi UFJ Trust & Banking opened a new position in Vaxcyte (PCVX) in Q2 2026: 3,146 shares worth $183K. The stake represents ﹤0.01% of the portfolio and ranks #1349 among its holdings.

116 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

  • Mitsubishi UFJ Trust & Banking held 3,146 shares of Vaxcyte worth $183K as of Q2 2026.
  • Vaxcyte was a new Mitsubishi UFJ Trust & Banking position in Q2 2026.
  • Vaxcyte made up ﹤0.01% of Mitsubishi UFJ Trust & Banking's portfolio in Q2 2026, its #1349 holding.
  • 116 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on Mitsubishi UFJ Trust & Banking's 13F filing for Q2 2026, filed 6 Aug 2026.